RE
NVRO

RBC Europe’s NEVRO CORP. NVRO Stock Holding History

RBC Europe’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-275
Closed -$23.6K – 1069
2019
Q3 		$23.6K Hold
275
– – ﹤0.01% 594
2019
Q2 		$17.8K Hold
275
– – ﹤0.01% 677
2019
Q1 		$17.2K Hold
275
– – ﹤0.01% 681
2018
Q4 		$10.7K Hold
275
– – ﹤0.01% 769
2018
Q3 		$15.7K Hold
275
– – ﹤0.01% 744
2018
Q2 		$22K Buy
+275
New +$22.8K ﹤0.01% 657

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RBC Europe's NVRO Position: Q4 2019 in Review

RBC Europe sold out of NEVRO CORP. (NVRO) in Q4 2019, closing a stake of 275 shares — an estimated $23.6K sold.

RBC Europe first reported a position in NVRO in Q2 2018 and held it in 6 quarters. The position peaked at $23.6K in Q3 2019. 191 funds tracked by Wall St. Rank hold NVRO as of Q4 2019.

  • RBC Europe reported no remaining NEVRO CORP. position as of Q4 2019 after selling out during the quarter.
  • RBC Europe sold 275 NEVRO CORP. shares in Q4 2019, an estimated $23.6K.
  • RBC Europe first reported a position in NEVRO CORP. in Q2 2018 and held it in 6 quarters.
  • RBC Europe's NEVRO CORP. position peaked at $23.6K in Q3 2019.
  • 191 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2019.

Based on RBC Europe's 13F filing for Q4 2019, filed 9 Nov 2023.